Collegium to Participate in Upcoming Investor Conferences

STOUGHTON, Mass., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that management will participate in the following investor conferences during the month of September:

H.C. Wainwright 23^rd Annual Global Investment Conference
Format: Fireside chat
Date: Monday, September 13, 2021
Time: 7:00 – 7:30 AM Eastern Time

Cantor Virtual Global Healthcare Conference
Format: Virtual presentation
Date: Tuesday, September 28, 2021
Time: 8:00 – 8:30 AM Eastern Time

The presentations will be webcast live and may be accessed from the Investor section of the Company’s website: https://ir.collegiumpharma.com. A replay of the webcasts will be available on the Company’s website for approximately 30 days after the event.

About Collegium Pharmaceutical, Inc.

Collegium is a specialty pharmaceutical company committed to being the leader in responsible pain management. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the company’s website at www.collegiumpharma.com.

Contact:
MacDougall Advisors
collegium@macbiocom.com